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Obesity-induced insulin resistance is a risk factor for diabetes and cardiovascular disease. However, the mech
anisms underlying endothelial senescence in obesity, and how it impacts obesity-induced insulin resistance
remain incompletely understood. In this study, transcriptome analysis revealed that the long non-coding RNA
(lncRNA) Maternally expressed gene 3 (Meg3) is one of the top differentially expressed lncRNAs in the vascular
endothelium in diet-induced obese mice. Meg3 knockdown induces cellular senescence of endothelial cells
characterized by increased senescence-associated β–galactosidase activity, increased levels of endogenous su
peroxide, impaired mitochondrial structure and function, and impaired autophagy. Moreover, Meg3 knockdown
causes cellular senescence of hepatic endothelium in diet-induced obese mice. Furthermore, Meg3 expression is
elevated in human nonalcoholic fatty livers and nonalcoholic steatohepatitis livers, which positively correlates
with the expression of CDKN2A encoding p16, an important hallmark of cellular senescence. Meg3 knockdown
potentiates obesity-induced insulin resistance and impairs glucose homeostasis. Insulin signaling is reduced by
Meg3 knockdown in the liver and, to a lesser extent, in the skeletal muscle, but not in the visceral fat of obese
mice. We found that the attenuation of cellular senescence of hepatic endothelium by ablating p53 expression in
vascular endothelium can restore impaired glucose homeostasis and insulin signaling in obesity. In conclusion,
our data demonstrate that cellular senescence of hepatic endothelium promotes obesity-induced insulin resis
tance, which is tightly regulated by the expression of Meg3. Our results suggest that manipulation of Meg3
expression may represent a novel approach to managing obesity-associated hepatic endothelial senescence and
insulin resistance.

1. Introduction
Cellular senescence is a stable form of cell cycle arrest that can be
induced by various stressors. Senescent cells display a number of hall
marks, including DNA damage, mitochondrial dysfunction, and
increased cyclin-dependent kinase inhibitors and senescence-associated
β-galactosidase (SA-β-gal) activity [1–4]. It is increasingly recognized

that cellular senescence is heterogeneous and cell-specific with pleio
tropic function [1,5–7]. Senescent cells are required for tissue remod
eling and morphogenesis during embryonic development [8,9], are
essential for wound healing [10], and promote heart regeneration after
injury [11,12]. In contrast, targeted elimination of senescent cells pre
vents neurodegeneration [13], extends healthy life [14], and prevents
Type 1 diabetes [15]. Recently, it was demonstrated that elimination of
senescent cells improved glucose tolerance, enhanced insulin sensitivity,
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generate p53fl/fl-Cre mice (p53 iECKO). A mouse model of diet-induced
obesity was used in our studies. It has been widely used to dissect mo
lecular mechanisms in obesity and obesity-impaired insulin signaling
[26–31]. To examine Meg3 expression in lean and obese mice, two
groups of C57BL/6J mice were used: one group was fed a high-fat diet
(HFD; Research Diets D12492, 60% calories from fat) at 7 weeks of age
for 4 or 8 weeks, and the second group was fed a control diet for D12492
(Research Diets D12450J, 10% calories from fat, matching sucrose and
protein to D12492). To examine the effects of Meg3 on cellular senes
cence and glucose homeostasis, C57BL/6J mice or other mouse lines
(see below) were fed a HFD (60% calories from fat, Research Diets
D12492) at 7 weeks of age for 12 weeks. The p53 floxed mice or p53
iECKO mice were injected daily with tamoxifen (Sigma T5648; intra
peritoneal 50 mg/kg) in corn oil for 5 days at 3–4 weeks of age as
described [32]. Immediately after the last tamoxifen injection, p53fl/fl or
p53 iECKO mice were fed a 60% HFD for 12 weeks. At Week 5 on HFD,
C57BL/6J, p53fl/fl, or p53 iECKO mice were randomly assigned into two
groups and injected weekly with either negative control gapmeRs or
Meg3 gapmeRs (intravenous 5 or 10 mg/kg) for 5 or 6 weeks. In vivo
ready mouse Meg3 gapmeR (5′ -TCATCAGTCAGTAGGT-3′ ) and LNA
antisense negative control A (5′ -AACACGTCTATACGC -3′ ) were pur
chased from Qiagen. To examine the effects of Meg3 knockdown on
insulin signaling cascade in vivo, the mice were injected with insulin
(0.75 U/kg Humulin R) after overnight fasting. The tissues were
collected at 10 min after insulin injection.

Abbreviations
CDKN1A
CDKN2A
ECs
eWATs
GTTs
HFD
HUVECs
IRβ
ITTs
LC3
LncRNAs
Meg3
NAFLD
NASH
OCR
SA-β-gal

cyclin-dependent kinase inhibitor 1A
cyclin-dependent kinase inhibitor 2A
endothelial cells
epididymal white adipose tissues
glucose tolerance tests
high-fat diet
human umbilical vein cells
insulin receptor β
insulin tolerance tests
microtubule associated protein 1 light chain 3
long non-coding RNAs
maternally expressed gene 3
nonalcoholic fatty liver disease
nonalcoholic steatohepatitis
O2 consumption rate
senescence-associated β-galactosidase

reduced macrophage accumulation in adipose tissue, lowered circu
lating inflammatory mediators, and promoted adipogenesis in obese
mice [16]. These results indicate that cellular senescence is a causal
factor in obesity-related inflammation and metabolic derangements.
However, the role of senescent endothelial cells (ECs) in regulating the
induction and exacerbation of obesity-induced insulin resistance is
largely unknown [17].
Long non-coding RNAs (lncRNAs) are a subgroup of non-protein
coding RNA transcripts that regulate gene expression in a range of
signaling pathways, and changes in their expression and function
contribute to the pathogenesis of human diseases [18–20] Emerging
studies have shown that they are important regulators of cell stress re
sponses [19–22]. We found that lncRNA Maternally expressed gene 3
(Meg3) protects endothelial function by regulating the DNA damage
response [23]. In the present study, we identified Meg3 as a top differ
entially expressed lncRNA in the vascular endothelium of obese mice,
and examined the role of Meg3 in regulating obesity-induced endothe
lial senescence and insulin resistance. We found that the loss of Meg3
induced hepatic endothelial senescence, and impaired glucose homeo
stasis and insulin signaling in obese mice. Meg3 knockdown induced
cellular senescence by impeding mitochondrial function, facilitating the
formation of mitochondria-derived reactive oxygen species, and
impairing autophagy. Our findings demonstrate that hepatic endothelial
senescence promotes obesity-induced insulin resistance.

2.2. Human liver specimens
Gene expression in human liver specimens was performed under the
Institutional Review Board (IRB) Approval #: 20190419315EX. Normal
human liver and pathologic human liver were obtained through the
Liver Tissue Cell Distribution System, Minneapolis, MN.
2.3. Glucose tolerance and insulin tolerance tests
Glucose tolerance tests (GTTs) and insulin tolerance tests (ITTs) were
performed as described in our previous studies [33]. For GTTs, mice
were fasted for 12 h, and then injected with D-glucose (intraperitoneal
1.0 g per kg of body weight). ITTs were performed on mice after 6 h of
fasting. Insulin (0.75 U/kg Humulin R) were given to mice by intra
peritoneal injection. Blood glucose levels were measured before injec
tion and at 15, 30, 60, 90, and 120 min after glucose or insulin injection
using One Touch Ultra glucometer.
2.4. Cell culture
Human Umbilical Vein Cells (HUVECs) (cc-2159) were obtained
from Lonza Group Ltd. and cultured in EC growth medium EGM-2 (cc3162). Cells used for all experiments were subcultured <8 times.
HUVECs (90,000/well) were plated into 12-well plates, transfected with
10 nM gapmeRs (LNA-modified antisense oligonucleotides) when cells
reached 80–90% confluency. Lipofectamine 2000 (Thermo Fisher Cat#
11668019) was used following the manufacturer instructions. Human
Meg3 gapmeR (5′ -GTAAGACAAGCAAGAG-3′ ), and LNA antisense
negative control A (5′ -AACACGTCTATACGC -3′ ) were purchased from
Qiagen.
For western blot analysis of p62 and LC3 II, HUVECs were treated
with 100 nM Bafilomycin A1 (Sigma Cat# B1793) for 4 h. For SA-β-gal
staining, cells were treated with 20 nM rapamycin (Sigma Cat# R8781)
for 48 h.

2. Materials and methods
2.1. Mice
All methods reported herein were carried out in accordance with
relevant guidelines and regulations of the University of Nebraska –
Lincoln (UNL). All experimental protocols were reviewed and approved
by UNL Institutional Biosafety Committee (Protocol Number: IBC788).
Mouse experiments were performed in accordance with Public Health
Service (PHS) animal welfare policy, the principles of the NIH Guide for
the Care and Use of Laboratory Animals, and the policies and procedures
at UNL. All animals were maintained in the UNL’s centralized Life Sci
ences Annex facility, which is accredited by the Association for Assess
ment and Accreditation of Laboratory Animal Care. Mouse experiments
were performed under Institutional Animal Care and Use Committee
(IACUC) Protocol# 1820 (breeding) and Protocol# 1819 (experiments).
C57BL/6J mice were ordered from the Jackson Laboratory (stock
#000664). The p53 floxed mice (Jackson stock #008462; p53fl/fl) were
bred with Cdh5CreERT2 Cre mice [24,25] for two or three rounds to

2.5. Endothelial cell isolation
For the sample preparation for RNA-seq, C57BL/6J mice were or
dered from the Jackson Laboratory (stock #000664). Mice were fed on a
high-fat diet (60% calories from fat, Research Diets D12492) at 8 weeks
2
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of age for 5 weeks (6 mice; n = 2 mice each sample). Mice fed on a
regular chow diet were used as controls (9 mice; n = 3 mice each
sample). For other experiments, mice were fed on a 60% HFD or treated
as indicated before EC isolation. The method for isolation of mouse ECs
was modified from previous studies [33–36]. Mice were euthanized by
30% isoflurane. Livers, eWATs, or skeletal muscles were harvested,
washed with 1 x dPBS to remove any contaminants. Tissues were minced
into small pieces with scissors followed by digestion with 10 ml diges
tion buffer (collagenase type 2, Worthington-Biochem, Cat# LS004177,
1mg/ml in DMEM/F12; dipase II, Roche, Cat# 04942078001, 1 mg/ml
in DMEM/F12) for 40 min in a 37 ◦ C shaker. Cell slurry was transferred
onto a 100 μm cell strainer pre-wet with equal volume of wash medium
(DMEM/F12 medium with 10%FBS), then span at 500×g for 10 min.
Supernatant was gently aspirated and discarded, and cell pellet was
re-suspended in 10 ml wash medium followed by second filtering with
40 μm cell strainer and spinning at 500×g for 10 min. Supernatant was
gently aspirated and cell pellet was mixed with 1 ml incubation buffer
(0.1% BSA, 2 mM EDTA and 0.5% FBS in 1 x dPBS). Cell suspension was
incubated with sheep anti-rat IgG Dynabeads (Thermo Fisher, Cat#
11035) coated with PECAM-1 antibodies (Becton Dickinson Co, Cat#
557355) and tumbled at 4 ◦ C for 15 min. After incubation, beads were
separated by using magnetic separation rack (NEB, Cat# S1509S), and
washed with 1 ml of 0.1% BSA in PBS twice, then mixed with 500 μl
TRIzol reagent for each sample followed by RNA extraction according to
the manufacturer’s instructions.

1-hydroxy-3-methoxycarbonyl-2, 2, 5, 5-tetramethylpyrrolidine (CMH)
was added to get 200 μM final concentration, and incubated for 30 min
at 37 ◦ C. Then, 900 μl of buffer was removed and cells were collected by
scraping in the remaining 100 μl. The sample (50 μl) was then loaded
into a glass capillary tube and inserted into the capillary holder of a
Bruker e-scan EPR spectrometer. The following EPR spectrometer set
tings were used: field sweep width, 60.0 G; microwave frequency, 9.74
kHz; microwave power, 21.90 mW; modulation amplitude, 2.37 G;
conversion time, 10.24 ms; time constant, 40.96 ms. The EPR spectrum
amplitude, which is directly proportional to the levels of free radicals in
the sample, was normalized to cell number in each sample.
2.9. Assessment of mitochondrial bioenergetics
To measure mitochondrial respiration, transfected HUVECs were
plated in 24-well Seahorse culture plates (95% confluency, 20,000 cells/
well) one day prior to measurement. For O2 consumption rate (OCR)
measurement, cell culture media were changed to modified XF assay
medium containing 10 mM glucose, 1 mM sodium pyruvate and 2 mM Lglutamine. Following 1 h incubation at 37 ◦ C without CO2, OCR were
measured using Seahorse XFe24 extracellular flux analyzer according to
manufacturer’s instruction in response to the respiratory chain in
hibitors: 1 μM Oligomycin, 1 μM FCCP, 1.5 μM antimycin A and 3 μM
rotenone.
2.10. RNA sequencing and analysis

2.6. Senescence-associated β-gal staining

Total RNAs were extracted from the isolated ECs using TRIzol re
agent (ThermoFisher, Cat# 15596018) according to the manufacturer’s
instructions. RNA samples were in triplicates. RNA-seq analysis was
performed by Genewiz (Formerly Beckman Coulter Genomics). Ribo
somal RNAs were depleted using TruSeq Stranded Total RNA with RiboZero Gold kit. Then, stranded RNA-seq automated libraries were con
structed for sequencing on an Illumina HiSeq 2500 (2 x 100 bp). After
obtaining raw reads, FastQC was used to analyze the quality of the reads.
The number of quality control-passed reads is at least 45 million per
sample. Tophat2 and bowtie [44–46] were used to map the reads to the
genome, GRCh38, Ensembl release 82 [47], and cufflinks [48] was used
to determine transcript expression. Cuffdiff [49] was used to generate
FPKM values and edgeR [50–53] was used for differential expression
analysis. Heatmap was generated using the R pheatmap package, and
genes were ranked on logFC of FPKMs.

HUVECs were seeded into two T25 flasks (750,000 cells/flask), and
transfected with 10 nM negative control or Meg3 gapmeRs using Lip
ofectamine 2000 on the next day. After 16 h, medium was replaced and
changed every two days. On day 5 after transfection, cells were plated to
12-well plate (90,000 cells/well). For double knockdown of p53 and
Meg3, HUVECs (750,000 cells/flask) were seeded into two T25 flasks.
Cells were transduced by lentiviral control shRNA or p53 shRNA
generated as described in our previous studies [23]. After 24 h, cells
were split to two flasks. On the next day, cells were transfected with
negative control or Meg3 gapmeRs using Lipofectamine 2000. Medium
were changed at 16 h post-transfection and cells were plated into
12-well plate (90,000 cells/well) at 72 h after transfection. β-galacto
sidase staining was performed using Senescence β-galactosidase Staining
Kit according to the manufacturer’s instructions (Cell Signaling Tech
nology, #9860) at 96 h post-transfection.

2.11. Immunofluorescence and imaging

2.7. MitoSOX staining

Tissues were fixed in 10% formalin (Sigma, Cat# HT5012-60 ML) for
24 h at 4 ◦ C. The fixed tissues were immersed in 10% sucrose for 2 days
and subsequently in 30% sucrose for 2 days. Then the tissues were
embedded in cryomolds with optimal cutting temperature compound
(Fisher Scientific, Cat# 4585) and allowed to freeze on dry ice. Frozen
tissues were sectioned using cryostat microtome and the sections were
mounted on poly-lysine coated slides (Thermo Fisher, Cat# P4981-001).
The slides with mounted tissue sections were immersed in 1:1 solution of
acetone:methanol mixture at 4 ◦ C for 10 min and then washed with 1 x
dPBS containing 0.3% Triton X-100 (PBST) three times with 5 min for
each. The sections were then blocked with 0.3% PBST containing 5%
goat serum and 1% BSA. Primary antibodies at dilutions, 1:100 for p21
(Abcam, Cat# Ab188224), 1:100 for CD31 (BD, Cat# 550274), 1:500 for
CD68 (BioLegend, Cat#137001), 1:2000 for Mac-2 (Cedarlane, Cat#
CL8942AP), 1:500 for perilipin (Cell Signaling Technology, Cat# 9349S)
were used for overnight staining at 4 ◦ C. Slides were washed three times
with 0.3% PBST for 5 min each. Subsequently, the slides were incubated
with appropriate secondary antibodies at dilution, 1: 200 for DyLight®
549 anti-Mouse IgG (Vector, Cat# DI-2549); 1:200 for DyLight® 649
anti-Rabbit IgG (Vector, Cat# DI-1649); 1:200 for Cy™3 AffiniPure goat
anti-Rat IgG (H + L) (Jackson Immunoresearch, Cat# 112-165-167)

To measure mitochondrial superoxide production, HUVECs were
stained with MitoSOX™ Red superoxide radical-specific reagent as
described [37–39]. HUVECs were incubated with 1 μM MitoSOX dye
(Thermo Fisher, Cat# M36008) in 1 x HBSS with Ca2+ and Mg2+ for 10
min, washed three times with 1 x HBSS with Ca2+ and Mg2+. Cells were
trypsinized and re-suspended in 1 x HBSS buffer with Ca2+ and Mg2+ for
flow cytometry analysis immediately [40,41]. MitoSOX was excited
with 488 nm laser, and Texas red filter (610/40 nm) was used to detect
the emission by flow cytometry.
2.8. Electron paramagnetic resonance (EPR) spectroscopy
HUVECs were transfected with 10 nM control gapmeRs or Meg3
gapmeRs. 40 h post-transfection, cells were collected for EPR as
described previously [42,43]. After removing cell culture media, cells
were incubated in 1 mL of Krebs-HEPES Buffer (pH 7.4) containing (in
mM): 99 NaCl, 4.69 KCl, 2.5 CaCl2, 1.2 MgSO4, 25 NaHCO3, 1.03
KH2PO4, 5.6 D-glucose, 20 HEPES, and supplemented with the metal
chelators deferoxamine (25 μM) and diethyldithiocarbamic acid sodium
salt (5 μM). The superoxide-sensitive EPR spin probe,
3
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with DAPI for nuclear staining for 1 h at room temperature. After the
slides were washed three times with 0.3% PBST, 5 min each, they were
mounted with coverslips using Fluoromount-G® (Southern biotech,
Cat# 0100–01) and allowed to dry overnight in dark at room temper
ature. Images were captured using Fluorescent microscope. Three
random fields per tissue sample were captured and the images were
analyzed for appropriate staining.

Mitochondrial structure was analyzed using a custom-modified NIH
ImageJ macro [55,56]. Form factor = Perimeter^2/(4 × Pi × area).
Mitochondrial perimeter is defined as the number of pixels forming the
boundary of a mitochondrial region.
2.15. ELISA
Plasma levels of insulin, adiponectin, TNF-α, MCP-1 were measured
by Eve Technologies Corp., and plasma levels of AST and ALT were
measured by the Biomedical and Obesity Research Core at UNL.

2.12. Quantitative real-time PCR (qPCR)
RNA was collected from HUVECs or mouse tissues using TRIzol Re
agent (Thermo Fisher, Cat# 15596026) according to the manufacturer’s
instructions. 1 μg of RNA was converted to cDNAs using the High Ca
pacity cDNA Reverse Transcription Kit (Thermo Fisher, Cat# 4368814).
qPCRs were conducted in the CFX Connect Real Time System (BioRad)
using 2x SYBR Green qPCR Master Mix (Bimake, Cat# B21203). Data
was normalized by the ΔΔCt method [54]. Primer sequences are listed in
the Supplementary Table 1.

2.16. Statistical analysis
For two-group comparisons, paired or unpaired Student’s t-test was
used for data that passed normality and equal variance test; otherwise, a
nonparametric Mann-Whitney U test will be used. For multiple groups,
one-way ANOVA followed by Tukey’s post hoc test was used for data
that passed normality and equal variance test; otherwise one-way
ANOVA followed by Holm’s post hoc test will be used. Normality will
be checked with the Kolmogorov-Smirnov test. An alpha level of 0.05
were used to determine significant differences, and data are reported as
mean ± SEM.

2.13. Western blot analysis
Mouse tissues were homogenized in RIPA buffer (25 mM Tris-HCl pH
7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) that
was supplemented with protease and phosphatase inhibitors. Cell ly
sates were collected after spinning at 13,000×g for 10 min. Protein
concentrations were measured by using the Pierce BCA Protein Assay Kit
(Thermo Fisher). 10 μg of protein was loaded per sample and the sam
ples were separated by SDS-PAGE using a 10% or 12% acrylamide gel.
After SDS-PAGE, the samples were transferred to Immun-Blot PVDF
Membranes using the Trans Blot Turbo Transfer System (BioRad; 25 V,
1.0 A, 30 min). After blocking with 5% nonfat milk in TBST, membranes
were incubated with corresponding antibodies. Then the blot was pro
bed with HRP-conjugated anti-rabbit (Cell Signaling Technology, Cat#
7074). ECL Plus Western blotting detection reagents (GE Healthcare,
Cat# RPN2132) were used to visualize proteins. ImageJ software (Na
tional Institutes of Health) was used to analyze protein abundance.
Antibodies used in this study include anti-Phospho-Akt (Ser473) (Cell
Signaling Technology, Cat# 4060S), anti-Akt (Cell Signaling Technol
ogy, Cat# 4691S), anti-p62 (MBL international, Cat# PM045), antiLC3B (Cell Signaling Technology, Cat# 3868S), anti-Phospho-IGF-I Re
ceptor β (Tyr1135/1136)/Insulin Receptor β (Tyr1150/1151) (Cell
Signaling Technology, Cat# 3024S), anti-Insulin Receptor β (Cell
Signaling Technology, Cat# 3025S), anti-p53 (Cell Signaling Technol
ogy, Cat# 9282S), and anti-GAPDH (Cell Signaling Technology, Cat#
5174). Protease inhibitor cocktail tablets were from Roche Diagnostics.
Phosphatase inhibitor was from Active Motif.

3. Results
3.1. Endothelial Meg3 expression is elevated in obesity
To identify differentially expressed lncRNAs in vascular endothelium
in obese mice, the ECs of epididymal white adipose tissues (eWATs)
were isolated from lean and obese mice for global transcriptomic anal
ysis using RNA-seq (Fig. 1A). The bioinformatics analysis identified 34
differentially expressed lncRNAs using edgeR (Fig. 1B). Among these
lncRNA transcripts, Meg3 is one of the top induced lncRNAs (Fig. 1B).
We examined Meg3 expression in the vascular endothelium of major
insulin target organs in lean and obese mice. After 4 weeks of high-fat
diet (HFD), Meg3 expression was induced by 1.6-, 1.5-, and 1.7-fold in
ECs isolated from eWATs, skeletal muscles, and livers of obese mice,
respectively; after 8 weeks of HFD, Meg3 expression was induced by 2.0, 1.9-, and 2.3-fold, respectively (Fig. 1C). Meg3 expression is higher in
the ECs from eWAT compared to those from the skeletal muscle or liver
(Fig. 1D). Meg3 in situ hybridization revealed that the majority of Meg3
is expressed in the nucleus of mouse and human adipose tissues colocalizing with the nuclei of adjacent CD31 positive cells (Fig. S1).
These data demonstrate that Meg3 is induced in the vascular endothe
lium of diet-induced obese mice.
3.2. Meg3 knockdown causes cellular senescence in HUVECs

2.14. Live cell imaging

Meg3 expression is elevated in senescent HUVECs compared with
early passage cells [57], and in HUVECs exposed to oxidative stress [58]
and hypoxia [59]. We have shown that DNA damaging agents induced
Meg3 expression in HUVECs in a p53-dependent manner, and Meg3
knockdown induced DNA damage and inhibited EC proliferation [23].
Meg3 knockdown also reduced the telomere length in HUVECs [60].
However, the role of Meg3 in cellular senescence has not been thor
oughly investigated.
Here, we studied the effects of Meg3 on cellular senescence by
examining several complementary hallmarks of cellular senescence in
HUVECs, including SA-β-gal activity, mitochondrial dysfunction, and
autophagy (Fig. 2). SA-β-gal activity is one of the commonly used marker
for senescence in vitro and in vivo [61,62]. We found that Meg3 knock
down increased the levels of SA-β-gal activity by 2.7-fold (Fig. 2A).
Mitochondrial dysfunction and mitochondria-derived superoxide are
key hallmarks of cellular senescence [63–66]. We asked whether Meg3
knockdown
increases
levels
of
superoxide
in
HUVECs.
Superoxide-specific MitoSOX staining and flow cytometry revealed that

Live cell imaging was carried out using a Nikon A1R-TiE (inverted)
confocal live-cell imaging system. An incubation chamber was used to
maintain the live cell conditions (5% CO2 and 37 ◦ C with humidity).
Cells cultured in a 35 mm glass bottom dish were used for imaging using
100x (NA 1.4) oil immersion lens with the help of NIS elements software
by sequential scanning, where applicable. For mitochondrial network
staining, cells were incubated with 300 nM MitoTracker Deep Red dye at
37 ◦ C for 10 min in 1 x HBSS with calcium and magnesium and washed
twice before imaging. Cells were excited by 640 nm laser and emissions
were collected at 640–690 nm range. HUVECs were also stained with
500 nM MitoTracker Green for 30 min and treated with 10 μM FCCP for
10 min for live cell imaging. For membrane potential staining, cells were
stained with 5 μg/ml JC-1 dye at 37 ◦ C for 15 min in 1 x HBSS with
calcium and magnesium and washed twice. JC1 was excited by the 488
nm and 561 nm lasers, and emissions were collected between 500 - 550
nm and 570–620 nm. Nuclei stained with Hoechst was excited at 405 nm
wavelength laser and emission was collected between 425 and 475 nm.
4
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Fig. 1. LncRNA Meg3 expression is induced in
vascular endothelium of obese mice. (A) Workflow of
genome-wide RNA-seq profiling for the identification
of differentially expressed lncRNAs (fold change >1.5;
FDR<0.1; mean FPKM greater than 2 in at least one
group). (B) Heatmap displaying significantly dysre
gulated lncRNAs identified by edgeR. (C) Meg3
expression was detected in the ECs isolated from the
eWATs, livers, or skeletal muscles (SM) of lean or
obese mice by qPCR. Mice were fed a control diet or
high-fat diet (HFD) for 4 weeks (n = 7–10 for lean and
n = 9–12 for obese) or 8 weeks (n = 8 for lean and n
= 8 for obese). (D) Meg3 expression was compared
among ECs from eWATs, livers, and skeletal muscles.
The expression of Meg3 in eWATs was set as 100 (n =
15 mice). For all panels, values are mean ± SEM; *, P
< 0.05.

HUVECs with Meg3 knockdown showed a marked increase in superox
ide (Fig. 2B). Free radicals, primarily superoxide, were measured by
Electron Paramagnetic Resonance (EPR) Spectroscopy [42,43]. Consis
tent with the MitoSOX staining data, HUVECs with Meg3 knockdown
displayed a significant increase in superoxide levels compared to control
cells (Fig. 2C), as indicated by an increase in the EPR spectrum ampli
tude. We examined the effects of Meg3 knockdown on mitochondrial
bioenergetic function in HUVECs including mitochondrial respiration
and cellular glycolysis. Meg3 knockdown reduced the basal mitochon
drial O2 consumption rate and the maximal respiration capacity
(Fig. 2D). Meg3 knockdown did not affect the extracellular acidification
rate, which is a proxy to cellular glycolytic flux (Fig. S2). We next sought
to determine the effect of Meg3 knockdown on mitochondrial
morphology using a custom-modified NIH Image J macro [55,56]. We
found that mitochondria were predominantly fragmented in HUVECs
with Meg3 knockdown (Fig. 2E), which is comparable with the effects of
FCCP, a chemical uncoupler that potently induces mitochondrial frag
mentation (Fig. S3). These changes in mitochondrial network are asso
ciated with the attenuated mitochondrial membrane potential in
HUVECs with Meg3 knockdown (Fig. 2F). These data demonstrate that
Meg3 knockdown impairs mitochondrial structure and function. Finally,
we examined the effects of Meg3 knockdown on autophagy because
impaired autophagy can promote cellular senescence in ECs [67,68].
The expression of both p62 and LC3-II were induced by Meg3 knock
down in HUVECs under basal condition (Fig. 2G). When cells were
treated with Bafilomycin A1, both p62 and LC3-II accumulation were
comparable between control cells and cells with Meg3 knockdown,
though the expression of p62 showed a tendency towards statistical
significance (Fig. 2G). Our data demonstrate that Meg3 knockdown al
ters autophagic flux likely by impairing autophagy in HUVECs. More
over, the activation of autophagy by rapamycin attenuated Meg3
knockdown-induced SA-β-gal activity in HUVECs, suggesting that
Meg3 knockdown promotes cellular senescence likely by impairing
autophagy in HUVECs (Fig. 2H).

In summary, these data along with our published results showing
that Meg3 knockdown induced DNA damage and inhibited cell prolif
eration [23] demonstrate that Meg3 prevents cellular senescence in
HUVECs.
3.3. Meg3 knockdown causes cellular senescence in hepatic endothelium
in obesity
Our data suggest that Meg3 is required to limit endothelial senes
cence in vitro. This prompted us to ask if Meg3 knockdown affects
cellular senescence in mice. We used a mouse model of diet-induced
obesity in our studies. In this model, mice develop obesity, elevated
adiposity, glucose intolerance, moderate insulin resistance, and hyper
insulinemia compared with lean mice, which mimics human metabolic
derangements observed in obesity [69–73]. We employed locked nucleic
acid-modified antisense oligonucleotides (gapmeRs) that have been
used for highly efficient inhibition of lncRNA function [59,74,75]. Meg3
knockdown by intravenous delivery of Meg3 gapmeRs induced the
expression of p53 target genes GADD45A and RRAD by 2.4- and 1.7-fold,
respectively, in ECs isolated from the livers (Fig. 3A). Meg3 knockdown
also induced the expression of cyclin-dependent kinase inhibitors
including two markers of senescence [76–78] CDKN1A (encoding p21)
by 2.7-fold and CDKN2A (encoding p16) by 3.4-fold, in the ECs isolated
from the livers of obese mice (Fig. 3A). In the ECs isolated from skeletal
muscles, GADD45A is the only induced gene among these examined
genes, and its expression was elevated by 1.7-fold (Fig. 3A). In the ECs
isolated from the eWATs, CDKN2A is the only induced gene, and its
expression was elevated by 2.0-fold (Fig. 3A). These changes in gene
expression were associated with a 94.3%, 90.0%, and 75.2% reduction
of Meg3 expression in the ECs isolated from the liver, skeletal muscle,
and eWAT, respectively (Fig. 3B). The expression of p21 was also
examined by immunostaining on frozen liver sections. Meg3 knockdown
led to a 10.3-fold increase in the number of p21-positive cells that
co-localize with CD31-positive cells in the livers of obese mice (Fig. 3C).
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Fig. 2. Meg3 knockdown (KD) causes cellular senescence of HUVECs. HUVECs were transfected with 10 nM control gapmeRs or 10 nM Meg3 gapmeRs. (A) Fold
change of SA-β-gal positive cells were calculated from 36 images per condition (n = 3). (B) MitoSOX reagent staining and flow cytometry analysis (n = 3). (C) Levels
of endogenous free radicals, primarily superoxide, measured by electron paramagnetic resonance (EPR), with n = 10 or 11 replicates (n = 3). (D) Oxygen con
sumption rate (OCR) in HUVECs (n = 3). (E) Mitochondria revealed by mitoTracker deep red in live cells. 101 or 75 cells (n = 4) were analyzed. (F) Mitochondrial
membrane potential (ΔΨm) revealed by JC-1 staining in live cells. Data from 32 or 40 cells (n = 3). (G) Western blot analysis of p62 and LC3-II in the presence or
absence of bafilomycin A1 (Baf A1) (n = 3). N.S., non-significant. (H) Fold change of SA-β-gal positive cells were calculated from 30 images per condition in the
presence or absence of rapamycin (n = 3). For all panels, values are mean ± SEM; n = 3 refers to three independent experiments; *, P < 0.05. (For interpretation of
the references to colour in this figure legend, the reader is referred to the Web version of this article.)

In the liver, skeletal muscle, and eWAT tissues with a mixed cell pop
ulations, CDKN2A is the only gene induced by Meg3 knockdown among
examined genes; its expression was induced by 2-fold in the liver but not
in the skeletal muscle and eWAT (Fig. 3D). These data demonstrate that
Meg3 knockdown promotes cellular senescence of hepatic endothelium

with no or minimal effects on cellular senescence of other cell types in
the liver, skeletal muscle, and eWAT.
We next examined Meg3 expression in human liver specimens pro
vided by the Liver Tissue Cell Distribution System at the University of
Minnesota. Demographics of these liver specimens are shown in
6
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Fig. 3. Meg3 knockdown (KD) causes cellular senescence in hepatic vascular endothelium in obesity. (A–D) C57BL/6 mice were fed on a HFD and treated with
control gapmeRs (n = 6) or Meg3 gapmeRs (n = 7) as described in Methods. (A) The expression of senescent markers (CDKN1A and CDKN2A) and p53 target genes
(GADD45A and RRAD) were examined in the freshly isolated ECs of livers, skeletal muscles (SM), and eWATs by qPCR. (B) The expression of Meg3 were examined in
isolated ECs by qPCR. (C) Immunofluorescence staining of liver sections with anti-CD31 and anti-p21 antibodies. The percentage of p21 positive cells was calculated
among CD31 positive cells, which was set as 1 in mice injected with control gapmeRs. Several double positive cells are indicated by arrowheads. (D) The expression of
senescent markers (CDKN1A and CDKN2A) and p53 target genes (GADD45A and RRAD) were examined in livers, skeletal muscles, and eWATs tissues by qPCR. (E)
The expressions of Meg3, CDKN1A, and CDKN2A were analyzed in RNAs isolated from liver specimens of human subjects without fatty liver (n = 7), with nonalcohlic
fatty liver (NAFLD; n = 5) or nonalcohlic hepatosteatosis (NASH, the severe form of fatty liver; n = 7). For all panels, values are mean ± SEM; *, P < 0.05.

Supplementary Table 2. Nonalcoholic steatohepatitis (NASH) is the
more aggressive form of nonalcoholic fatty liver disease (NAFLD). Meg3
expression was elevated by 1.6- and 1.9-fold, respectively, in NAFLD and
NASH livers (Fig. 3E). Furthermore, CDKN1A expression was 1.8-fold
higher in NAFLD and 2.4-fold higher in NASH livers, respectively; and
the expression of CDKN2A was 8.8-fold higher in NASH livers (Fig. 3E).
Importantly, the expression of Meg3 positively correlates with CDKN2A
expression in these human liver specimens (Fig. 3E).
Taken together, these data suggest endogenous Meg3 limits cell
senescence of hepatic vascular endothelium in diet-induced obese mice
and has translational relevance to human subjects, although additional
features of cellular senescence such as impaired autophagy and mito
chondrial structure and function were not examined in hepatic endo
thelium in the present study.

3.4. Meg3 knockdown impairs insulin signaling and glucose homeostasis
Senescent cells are found in obesity [78–81]. Because we found Meg3
knockdown promotes cellular senescence in hepatic endothelium in
obesity, we next sought to examine the role of Meg3 in obesity-induced
insulin resistance and glucose homeostasis. The intravenous delivery of
Meg3 gapmeRs led to 94.8%, 89.8%, and 68.9% reduction of Meg3
expression in the liver, skeletal muscle, and eWAT, respectively
(Fig. 4A). Meg3 knockdown did not affect food intake, body weight,
physical activity, heat, carbon dioxide production, or oxygen con
sumption revealed by metabolic cage studies (Fig. S4). Glucose tolerance
test (GTT) and insulin tolerance test (ITT) revealed that Meg3
gapmeR-treated mice developed more severe glucose intolerance and
insulin resistance after being fed a HFD for 10 weeks (Fig. 4B and C). In
addition, Meg3 gapmeRs-treated mice had higher fasting plasma insulin
7
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Fig. 4. Meg3 knockdown (KD) induces obesity-associated insulin resistance. C57BL/6 mice were fed a HFD. At Week 5 on HFD, mice were intravenously injected
with control gapmeRs or Meg3 gapmeRs once a week and maintained on HFD up to 12 weeks. (A) Meg3 expression was examined in livers, skeletal muscles, and
eWATs tissues by qPCR. (B) Glucose and insulin tolerance tests. (C) Areas under curves (AUC) for GTT and ITT. (D) The fasting levels of plasma insulin and adi
ponectin were examined by ELISA. A small amount of blood were collected before insulin injection. (E) Total Akt and the phosphorylation of Akt at serine 473 were
examined by western blot in the indicated tissues of overnight-fasted mice. The tissues were collected at 10 min after insulin injection (0.75 units/kg). For all panels,
values are mean ± SEM, n = 6–7; *, P < 0.05.

levels but not adiponectin (Fig. 4D). To ensure these findings are linked
to changes in insulin signaling, we examined Akt phosphorylation at
serine 473 (pSer473-Akt) in the liver, skeletal muscle, and eWAT of
obese mice injected with insulin. Meg3 knockdown reduced the levels of
pSer473-Akt by 43% in the livers and by 32% in the skeletal muscles but
not in the eWATs in obese mice (Fig. 4E). We also examined the effects of
Meg3 knockdown on the levels of phosphorylated insulin receptor β
subunit (IRβ), a key upstream component of insulin signaling cascade.
Meg3 knockdown reduced the levels of phosphorylated IRβ by 50% in
the livers of obese mice (Fig. S5). These data demonstrate that Meg3
knockdown impairs systemic glucose homeostasis and insulin sensitivity
in the liver and skeletal muscle.

Chronic inflammation is a key driver of obesity-induced insulin
resistance [82–84]. Histological assessment of eWAT by macrophage
marker Mac2 revealed no differences between two groups of obese mice
injected with negative control or Meg3 gapmeRs (Fig. S6A). The
expression of TNF-α and ICAM-1 was unaltered at the mRNA levels in
eWAT (Fig. S6B). Interestingly, histological assessment of livers by CD68
staining revealed a 37% decrease in macrophage content in the HFD-fed
mice injected with Meg3 gapmeRs compared to livers of the HFD-fed
control mice (Fig. S6C). The mRNA expression of CD68 and F4/80
were also reduced, while the mRNA expression of MCP1 was unchanged
(Fig. S6D). In addition, the plasma levels of TNF-α and MCP1 were not
changed in mice with Meg3 knockdown (Fig. S6E), suggesting that Meg3
8
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knockdown had no effects on systemic inflammation. Finally, the levels
of plasma ALT and AST were not changed by Meg3 knockdown
(Fig. S6F). But interestingly, Meg3 knockdown induced type I interferon
response in hepatic endothelium as revealed by the induction of IFN-β
and IRGM (immunity-related GTPase family M) expression at mRNA
levels (Fig. S6G). Consistent with the data, Meg3 knockdown also
induced type I interferon response in HUVECs (Fig. S6G). These data
demonstrate that Meg3 knockdown-induced insulin resistance is un
likely to arise from its effects on systemic inflammation.
To interrogate the proteome regulated by Meg3 in vivo, livers were
collected for quantitative proteomics analysis (Fig. S7). TMT10-plex
labeling and mass spectrometry identified 104 differentially expressed
proteins (20% change with P < 0.05) (Supplementary Table 3). Genes
encoding these proteins were used for gene ontology (GO) term analysis.
The top 10 GO terms by fold enrichment are shown in Fig. S7. The top
three terms are “Mitochondrial respiratory chain complex I′′ , “Respira
tory chain”, and “Response to oxidative stress”, indicating that Meg3
knockdown impairs mitochondrial function in liver of obese mice. These
data suggest that Meg3 knockdown induces mitochondrial stress in vivo.
Taken together, these data demonstrate that Meg3 knockdown im
pairs systemic glucose homeostasis and insulin signaling in the liver and

skeletal muscle independent of its any effects on systemic inflammation.
3.5. Endothelial cell-specific p53 knockout attenuates Meg3 knockdowninduced cellular senescence in hepatic endothelium
An important question that we wished to address is whether cellular
senescence of the vascular endothelium impairs glucose homeostasis
and insulin signaling in obesity. Our data demonstrate that Meg3
knockdown induced hepatic endothelial senescence which is associated
with impaired glucose homeostasis and insulin signaling (Figs. 3 and 4),
but the cause-effect relationship between them has not been established.
Here, we examined whether p53 deficiency in endothelium can
attenuate cellular senescence in hepatic endothelium induced by Meg3
knockdown because p53 is a master regulator of cellular senescence and
glucose homeostasis [85,86]. We took a genetic approach to reduce p53
expression in the vascular endothelium. We used conditional p53 floxed
mice carrying tamoxifen-inducible Cre-recombinase under the regula
tion of the vascular endothelial cadherin promoter (p53 iECKO). The
deletion of the p53 gene in endothelium was induced by tamoxifen in
jection, leading to 45% and 87% decrease in p53 expression in hepatic
and skeletal muscle ECs, respectively, after 12 weeks (Fig. S8A). In

Fig. 5. Endothelial cell-specific p53 deletion attenuates Meg3 knockdown-induced cellular senescence of hepatic endothelium in obese mice. (A–C) p53 iECKO mice
were fed a HFD. At Week 5 on HFD, mice were intravenously injected with control gapmeRs or Meg3 gapmeRs (knockdown) once a week and maintained on HFD for
up to 12 weeks (n = 6–8 per group). (A) The expression of senescent markers (CDKN1A and CDKN2A) and p53 target genes (GADD45A and RRAD) were examined in
the freshly isolated ECs by qPCR. (B) The expression of senescent markers (CDKN1A and CDKN2A) and p53 target genes (GADD45A and RRAD) were examined in
livers and skeletal muscles (SM) tissues by qPCR. (C) Immunofluorescence staining of liver sections with anti-CD31 and anti-p21 antibodies. Arrowheads indicate
double positive cells. (D–E) p53 floxed mice (p53fl/fl) were fed a HFD. At Week 5 on HFD, mice were intravenously injected with control gapmeRs or Meg3 gapmeRs
once a week and maintained on HFD for up to 12 weeks (n = 6–9 per group). (D) The expression of senescent markers (CDKN1A and CDKN2A) and p53 target genes
(GADD45A and RRAD) were examined in the freshly isolated ECs by qPCR. (E) The expression of senescent markers (CDKN1A and CDKN2A) and p53 target genes
(GADD45A and RRAD) were examined in livers by qPCR. (F) SA-β-gal staining of HUVECs transduced with control lentivirus (shRNA-ctl) or lentivirus expressing p53
shRNA (shRNA-p53), and transfected with control gapmeRs or Meg3 gapmeRs. The percentages of SA-β-gal positive cells were analyzed and fold changes were
calculated relative to that in HUVECs transduced with shRNA-ctl and transfected with control gapmeRs. Data were from three independent experiments. For all
panels, values are mean ± SEM; *, P < 0.05.
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addition, the expression of p53 was reduced by 64% at protein levels in
the freshly isolated liver ECs of p53 iECKO mice (Fig. S8B), which
remarkably attenuated the expression of p21 at mRNA levels (Fig. S8C).
In contrast, the expression of p53 was not changed in the livers and
skeletal muscles (Fig. S8D). Systemic delivery of Meg3 gapmeRs reduced
the expression of Meg3 in both ECs and liver and skeletal muscle tissues
in either p53 iECKO (CadCreERT2:p53fl/fl) mice (Fig. S8E) or p53fl/fl
mice (data not shown).
We first examined the effects of Meg3 knockdown on cellular
senescence of hepatic endothelium in p53 iECKO mice (Fig. 5A–C). In
the ECs isolated from the livers, p53 deletion completely blocked the
induction of CDKN1A, GADD45A, and RRAD in p53 iECKO mice injected
with Meg3 gapmeRs as compared with that in mice injected with
negative control gapmeRs (Fig. 5A). Interestingly, the expression of
CDKN2A was still induced by Meg3 knockdown despite p53 deletion
(Fig. 5A). In the liver tissue, CDKN2A and RRAD were induced by 2.5and 1.7-fold, respectively (Fig. 5B). In the ECs isolated from the skeletal
muscles, p53 deletion blocked the induction of GADD45A by Meg3
knockdown (Fig. 5A). The expression of all examined genes was not
changed in the skeletal muscle (Fig. 5B). Of note, p21 expression was
barely detectable by qPCR and immunostaining in both groups of mice
(Fig. 5C, Fig. S8C), likely due to the deletion of p53.
We next examined the effects of Meg3 knockdown on cellular
senescence of hepatic endothelium in p53fl/fl mice (Fig. 5D and E).

Consistent with the data shown in Fig. 3, Meg3 knockdown causes
cellular senescence in hepatic endothelium in obese p53fl/fl mice. Spe
cifically, the expression of CDKN1A, CDKN2A, and GADD45A was
elevated by 1.5-fold, 2.3-fold, and 1.4-fold, respectively, in the ECs
isolated from the livers of obese p53fl/fl mice (Fig. 5D). The expression of
RRAD was not changed in this experiment probably because p53fl/fl mice
were less obese than those in Fig. 3.
We also examined the effects of p53 on Meg3 knockdown-induced EC
senescence revealed by SA-β-gal activity staining. The expression of p53
was dramatically reduced by lentiviral p53 shRNA in HUVECs (data not
shown). Meg3 knockdown led to a 1.6-fold increase in the number of SAβ-gal positive cells in HUVECs transduced with lentiviral control
shRNAs, which was abolished in HUVECs transduced with lentiviral p53
shRNA (Fig. 5F).
Taken together, our data demonstrate p53 deletion in vascular
endothelium can partially attenuate Meg3 knockdown-induced cellular
senescence of hepatic vascular endothelium in diet-induced obese mice.
3.6. Delaying the cellular senescence of hepatic endothelium by
endothelial cell-specific p53 knockout attenuates the impaired glucose
homeostasis and insulin signaling resulted from Meg3 knockdown
We have shown that p53 deficiency in hepatic endothelium can
attenuate Meg3 knockdown-induced cellular senescence in the hepatic

Fig. 6. Endothelial cell-specific p53 deletion attenuates Meg3 knockdown-impaired insulin signaling. (A–B) p53 iECKO mice were fed a HFD. At Week 5 on HFD,
mice were intravenously injected with control gapmeRs or Meg3 gapmeRs (knockdown) once a week and maintained on HFD for up to 12weeks (n = 6–8 per group).
(A) Glucose and insulin tolerance tests. (B) Total Akt and phosphorylated Akt at serine 473 were examined by western blot in the livers and skeletal muscles (SM) of
overnight-fasted mice. The tissues were collected at 10 min after insulin injection (0.75 units/kg). (C–E) p53 floxed (p53fl/fl) mice were fed a HFD. At Week 5 on HFD,
mice were intravenously injected with control gapmeRs or Meg3 gapmeRs once a week and maintained on HFD for up to 12 weeks (n = 5–8 per group). (C) Glucose
and insulin tolerance tests. (D) Areas under curves (AUC) for GTT and ITT. (E) Total Akt and phosphorylated Akt at serine 473 were examined by western blot in the
livers of overnight-fasted mice. The livers were collected at 10 min after insulin injection (0.75 units/kg). For all panels, values are mean ± SEM; *, P < 0.05.
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endothelium of obese mice. We next examined the role of cellular
senescence of hepatic endothelium in glucose homeostasis and insulin
signaling in obesity. Glucose tolerance test (GTT) and insulin tolerance
test (ITT) revealed that Meg3 gapmeR-treated mice did not develop
more severe glucose intolerance and insulin resistance after being fed a
HFD for 10 weeks (Fig. 6A), when p53 expression was absent in hepatic
endothelium. Next, we examined the effects of Meg3 knockdown on the
phosphorylation of Akt at serine 473 in the livers and skeletal muscles of
p53 iECKO mice (Fig. 6B). We did not examine the effect of Meg3
knockdown in eWAT in p53 iECKO mice, because Meg3 knockdown did
not affect the phosphorylation of Akt in eWAT (Fig. 4E). The deletion of
p53 in the vascular endothelium restored the phosphorylation of Akt in
p53 iECKO mice injected with Meg3 gapmeRs to a level comparable to
that observed in p53 iECKO mice injected with negative control gapm
eRs in both liver and skeletal muscle (Fig. 6B). Consistent with the data
in C57BL/6 mice (Fig. 4), Meg3 knockdown impaired glucose homeo
stasis and insulin signaling revealed by GTT, ITT, and western blot
analysis of Akt phosphorylation at serine 473 in p53 floxed mice
(Fig. 6C–E). Similarly, Meg3 knockdown also reduced the levels of
phosphorylated IRβ by 25% (Fig. S9). These data demonstrate that the
attenuation of cellular senescence of hepatic endothelium by deleting
p53 expression can restore impaired glucose homeostasis and insulin
signaling in obesity, suggesting that cellular senescence of hepatic
endothelium drives obesity-induced insulin resistance and dysregulation
of glucose homeostasis.

attenuate Meg3 knockdown-induced SA-β-gal activity (Fig. 2H) in
HUVECs. It is possible that Meg3 knockdown induces cellular senes
cence by impairing autophagy which results from the activation of p53
signaling upon Meg3 knockdown. It is also possible that Meg3 knock
down induces cellular senescence through cGAS-STING signaling, which
can be activated in response to mitochondrial stress and DNA damage
[89]. Indeed, Meg3 knockdown induces the expression of IFN-β and
IRGM in hepatic endothelium in obese mice, and the expression of IFN-β
and other interferon-stimulated genes in HUVECs (Fig. S6G), demon
strating that Meg3 knockdown activates type I interferon response in
vitro and in hepatic endothelium in obese mice. These findings raise the
possibility that cGAS-STING signaling contributes to cellular senescence
induced by Meg3 knockdown in vitro and in vivo. Further studies are
required to tease out the underlying molecular mechanism. One limi
tation to our data on Meg3’s role in cellular senescence is that HUVECs
were used for in vitro cell culture studies. Thus, our findings from
HUVECs may not fully recapitulate the effects of Meg3 on cellular
senescence of hepatic endothelium in obese mice. Specifically, the ef
fects of Meg3 on additional features of cellular senescence such as
impaired autophagy and mitochondrial structure and function were not
examined in primary mouse liver sinusoidal ECs or in hepatic endo
thelium of mice in the present study. Future studies are warranted to
provide further insights into this issue.
SQSTM1/p62 is a selective autophagy receptor that serves as a link
between microtubule associated protein 1 light chain 3 (LC3) and
ubiquitinated substrates of degradation [90]. During autophagy, p62,
LC3-II (a lipidated form of LC3), and substrates become incorporated
into autophagosomes and are degraded in autolysosomes (formed by the
fusion of autophagosomes with lysosomes) [91]. Thus, the accumulation
of p62 and LC3-II often correlates with impaired autophagy, while the
reduction of p62 and LC3-II often associates with autophagy activation
[91]. To exclude the possibility that the higher levels of p62 and LC3-II
could activate autophagy, the expression of p62 and LC3-II needs to be
examined in cells treated with Bafilomycin A1. It inhibits the degrada
tion of p62 and LC3-II by blocking autophagosome-lysosome fusion and
autolysosome acidification. When cells are treated with Bafilomycin A1,
the persistent increase in p62 and LC3-II expression by the experimental
condition indicates that autophagy is activated, while the normalization
of p62 and LC3-II accumulation, respectively, between control and
experimental conditions indicates that the accumulation of p62 and
LC3-II results from impaired autophagy under basal condition. Our data
in Fig. 2G demonstrate that Meg3 knockdown alters autophagic flux
likely by impairing autophagy in HUVECs. Furthermore, we speculate
that Meg3 knockdown leads to the accumulation of protein aggregates.
In this study, we examined the role of Meg3 in glucose homeostasis
and insulin signaling in obesity, which has not been previously exam
ined by other groups. GTT and ITT revealed that Meg3 knockdown
impairs glucose homeostasis in obesity (Fig. 4B and C). Meg3 knock
down decreases insulin-stimulated Akt phosphorylation in livers and
skeletal muscles (Fig. 4E), which is associated with an increase in fasting
plasma insulin levels (Fig. 4D). In contrast, Meg3 knockdown had no
effects on Akt phosphorylation in eWAT (Fig. 4E). The tissue-specific
effects of other genes on Akt phosphorylation in major insulin target
organs have been observed by other studies [92,93]. The tissue specific
effects of Meg3 on insulin signaling could be due to the different
microenvironment of different tissues. Chronic inflammation is a key
driver of obesity-induced insulin resistance [82–84]. Meg3 knockdown
had no effects on systemic inflammation (Fig. S6), suggesting Meg3
knockdown-induced insulin resistance is unlikely caused by its effects on
systemic inflammation.
Obesity accelerates cellular senescence [17,94,95]. Elimination of
p16-expressing senescent cells restored obesity-impaired neurogenesis
and alleviated obesity-induced anxiety and metabolic dysfunction in
obese mice [16,95]. However, the causal relationship between EC
senescence and insulin resistance has not been examined in obesity. To
answer the question, we employed a genetic approach to attenuate Meg3

4. Discussion
In the present study, we examined the role of Meg3 in cellular
senescence of HUVECs in vitro, and cellular senescence of hepatic
endothelium, glucose homeostasis, and insulin signaling in diet-induced
obesity. Our data demonstrate that: 1) Meg3 knockdown induces
endothelial senescence in vitro and cellular senescence of hepatic
endothelium in obese mice; 2) Meg3 knockdown impairs insulin
signaling and glucose homeostasis in obesity; and 3) hepatic endothelial
senescence promotes obesity-induced insulin resistance. Therefore,
Meg3 expression in the vascular endothelium maintains glucose ho
meostasis and insulin signaling by protecting the hepatic endothelium
against cellular senescence in obesity.
Cellular senescence is characterized by a number of hallmarks,
including mitochondrial dysfunction, DNA damage, and increased
expression of cyclin-dependent kinase inhibitors and SA-β-gal activity
[1,4,87,88]. As we have shown that Meg3 knockdown inhibits cell
proliferation, induces DNA damage [23], and others have shown that
Meg3 knockdown decreases the length of telomeres in HUVECs [60], we
wished to examine further markers of cellular senescence to firmly
establish Meg3 as an important player in cellular senescence. We
examined senescent hallmarks including SA-β-gal activity, mitochon
drial dysfunction, and autophagy (Fig. 2). Our data strongly demon
strate that Meg3 prevents endothelial senescence in vitro. Importantly,
we found Meg3 knockdown causes cellular senescence in hepatic
vascular endothelium in obese mice (Fig. 3). In addition, the expression
of Meg3 positively correlates with CDKN2A expression in human liver
specimens (Fig. 3E). CDKN2A encodes p16, a commonly used marker of
cellular senescence in vivo [3,77,78]. Meg3 expression was elevated by
1.6- and 1.9-fold, respectively, in NAFLD and NASH livers (Fig. 3E),
suggesting that Meg3 induction is likely a compensatory mechanism in
NAFLD and NASH livers in patients. Future studies will need to clarify
this point. These data demonstrate that Meg3 is an important regulator
of cellular senescence in vascular endothelium, which has not been
previously reported.
While the precise mechanisms by which Meg3 knockdown induces
cellular senescence are not fully elucidated, regulation of downstream
p53 signaling and autophagy likely contribute. In support, we showed
that p53 knockdown can block Meg3 knockdown-induced SA-β-gal ac
tivity (Fig. 5F), and the activation of autophagy by rapamycin can also
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knockdown-induced cellular senescence in obese mice. Specifically, we
used Cdh5CreERT2 Cre mice [24,25] to excise the floxed p53 exon in our
studies. These mice express Cre driven by VE-cadherin promoter that is
tamoxifen-inducible. This mouse line is most commonly used to excise
sequences flanked by loxP sites in vascular endothelium [96,97],
because it has more specific labelling of ECs than other mouse lines such
as Tie2-Cre [98]. Furthermore, it is commonly used to excise loxP-sites
flanking sequences in hepatic endothelium [97,99–101]. EC-specific
p53 deletion attenuates DNA damage/cell senescence in obese mice
[102]. Indeed, we found that EC-specific p53 knockout abrogates the
induction of p21 and other p53 target genes such as GADD45A and
RRAD upon Meg3 knockdown in hepatic vascular endothelium
(Fig. 5A). Meg3 knockdown-induced p16 expression still persists in
hepatic vascular endothelium with p53 deficiency, likely due to residual
p53 expression in hepatic vascular endothelium. Importantly, we found
that attenuation of hepatic EC senescence by EC-specific p53 knockout
restores the impaired glucose homeostasis and hepatic insulin signaling,
demonstrating that hepatic cell senescence promotes and attenuation of
hepatic cell senescence ameliorates obesity-induced insulin resistance.
In conclusion, our data demonstrate that cellular senescence of he
patic endothelium promotes obesity-induced insulin resistance, which is
tightly regulated by the expression of Meg3. Our data suggest that
manipulation of Meg3 expression may represent a novel approach to
managing obesity-associated hepatic endothelial senescence and insulin
resistance.

Center; and NIH Contract # HSN276201200017C to the Liver Tissue
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P30DK046200. Funding for open access charge: National Institutes of
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Appendix A. Supplementary data
Supplementary data to this article can be found online at https://doi.
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